Covid-19 Therapy: What Have We Learned In 8 Months?
SARS-CoV-2, a novel pathogenic human coronavirus, emerged in December of 2019 in Wuhan (Hubei province, China). In most cases, the infection causes a mild to moderate respiratory illness. However, a undefined group of infected may develop a severe or critical illness: Coronavirus disease 2019 (COVID...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2020-01-01
|
| Series: | Postępy Mikrobiologii |
| Subjects: | |
| Online Access: | https://doi.org/10.21307/PM-2020.59.3.15 |